NCT06734312View on ClinicalTrials.gov

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Obesity and Obesity-related Medical ConditionsObesity and OverweightObesity PreventionObesity RecidivismGLP-1Ablation Techniques
Interventions
DEVICE

Gastric Fundal Mucosal Ablation (GFMA)

Endoscopic Gastric Fundal Mucosal Ablation (GFMA) after discontinuation of GLP-1 therapy

Trial Locations (2)

27513

NOT_YET_RECRUITING

True You Weight Loss, Cary

RECRUITING

True You Weight Loss, Cary

All Listed Sponsors
lead

Dr. Christopher McGowan

OTHER